
Alphatec Holdings ATEC
$ 12.93
-0.92%
Annual report 2025
added 02-24-2026
Alphatec Holdings Interest Expense 2011-2026 | ATEC
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Alphatec Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.9 M | 24.9 M | 16.6 M | 5.5 M | 7.11 M | 12.4 M | 9.86 M | -7.14 M | -133 K | 5.37 M | 4 M | 3.02 M | 3.96 M | 6.1 M | 3.03 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 45.9 M | -7.14 M | 9.37 M |
Quarterly Interest Expense Alphatec Holdings
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.3 M | 7.84 M | - | 6.57 M | 5.82 M | 5.34 M | - | 4.46 M | 3.89 M | 3.87 M | - | 1.28 M | 1.44 M | 1.46 M | - | 1.27 M | 2.39 M | 1.94 M | - | 2.76 M | 3.03 M | 2.87 M | - | 2.92 M | - | -2.12 M | - | - | -75 K | 62 K | - | -15 K | 2 K | 5 K | - | 90 K | 3.72 M | 3.36 M | - | 3.11 M | 3.04 M | 3.37 M | - | 3.88 M | 3.75 M | 1.69 M | - | 1.05 M | 927 K | 695 K | - | 774 K | 3.58 M | 708 K | - | 725 K | 888 K | 679 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 12.3 M | -2.12 M | 2.51 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.21 | -0.43 % | $ 3.45 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 10.53 | 0.77 % | $ 1.42 B | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 9.69 | -13.17 % | $ 274 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.82 | -5.91 % | $ 142 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 8.32 | -0.48 % | $ 597 M | ||
|
Establishment Labs Holdings
ESTA
|
5.82 M | $ 65.54 | 0.81 % | $ 1.94 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.06 | -4.92 % | $ 859 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 70.78 | -0.59 % | $ 105 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 37.4 | 0.16 % | $ 1.16 B | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 16.8 | -2.38 % | $ 394 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.44 | -0.05 % | $ 121 M | ||
|
Abbott Laboratories
ABT
|
548 M | $ 109.06 | -1.49 % | $ 190 B | ||
|
Delcath Systems
DCTH
|
-70 K | $ 9.49 | -2.57 % | $ 340 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 269.13 | -0.13 % | $ 7.59 B | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.07 | -4.61 % | $ 1.26 M | ||
|
AxoGen
AXGN
|
167 K | $ 31.04 | -5.22 % | $ 1.43 B | ||
|
Align Technology
ALGN
|
7.68 M | $ 172.05 | -2.31 % | $ 12.9 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 8.93 | -1.92 % | $ 688 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 34.17 | 1.27 % | $ 5.09 K | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.74 | -0.13 % | $ 154 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
559 K | $ 0.39 | -0.46 % | $ 40.1 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 101.34 | -1.42 % | $ 1.29 B |